U.S. federal trademark · Serial No. 90864476
Providing medical information; providing medical information relating to therapies and treatments for cognitive impairment associated with schizophrenia and mental illness and disorders
Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of cognitive impairment associated with schizophrenia and mental illness and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of cognitive impairment associated with schizophrenia and mental illness and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of cognitive impairment associated with schizophrenia and mental illness and disorders, and evaluating epidemiological results for treatments for cognitive impairment associated with schizophrenia and mental illness and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for cognitive impairment associated with schizophrenia and mental illness and disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.